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Background: Few studies have evaluated health impacts, especially biomarker changes, following implementation
of a new environmental policy. This study examined changes in water fluoride, urinary fluoride (UF), and bone
metabolism indicators in children after supplying low fluoride public water in endemic fluorosis areas of Southern
China. We also assessed the relationship between UF and serum osteocalcin (BGP), calcitonin (CT), alkaline
phosphatase (ALP), and bone mineral density to identify the most sensitive bone metabolism indicators related to
fluoride exposure.
Methods: Four fluorosis-endemic villages (intervention villages) in Guangdong, China were randomly selected to
receive low-fluoride water. One non-endemic fluorosis village with similar socio-economic status, living conditions,
and health care access, was selected as the control group. 120 children aged 6-12 years old were randomly chosen
from local schools in each village for the study. Water and urinary fluoride content as well as serum BGP, CT, ALP
and bone mineral density were measured by the standard methods and compared between the children residing
in the intervention villages and the control village. Benchmark dose (BMD) and benchmark dose lower limit (BMDL)
were calculated for each bone damage indicator.
Results: Our study found that after water source change, fluoride concentrations in drinking water in all
intervention villages (A-D) were significantly reduced to 0.11 mg/l, similar to that in the control village (E). Except
for Village A where water change has only been taken place for 6 years, urinary fluoride concentrations in children
of the intervention villages were lower or comparable to those in the control village after 10 years of supplying
new public water. The values of almost all bone indicators in children living in Villages B-D and ALP in Village A
were either lower or similar to those in the control village after the intervention. CT and BGP are sensitive bone
metabolism indicators related to UF. While assessing the temporal trend of different abnormal bone indicators after
the intervention, bone mineral density showed the most stable and the lowest abnormal rates over time.
Conclusions: Our results suggest that supplying low fluoride public water in Southern China is successful as
measured by the reduction of fluoride in water and urine, and changes in various bone indicators to normal levels.
A comparison of four bone indicators showed CT and BGP to be the most sensitive indicators.* Correspondence: chshaox@mail.sysu.edu.cn
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Fluorine is the 13th most abundant naturally occurring
element in the earth’s crust [1]. It is a highly reactive elem-
ent which combines with other elements and molecules to
form fluorides in the Earth’s surface [2]. While scientists
are still uncertain whether fluoride is essential to human
health, many believe that small amounts of fluoride in the
diet can help prevent dental caries and strengthen bones
[3]. On the other hand, chronic ingestion of high doses of
fluoride has a number of adverse effects on human health,
including dental fluorosis and skeletal fluorosis [4,5],
increased bone fractures, decreased birth rates, increased
rates of urolithiasis (kidney stones), impaired thyroid func-
tion, and lower intelligence in children [6,7]. In China,
there are three major sources of excessive fluoride:
drinking water, coal pollution, and drinking brick tea
infusions, which lead to endemic dental and skeletal fluor-
osis [8-13]. According to China’s national prevention plan
(2004-2010) [14] for key endemic diseases, in the year
2003, there were about 3 million people suffering from
skeletal fluorosis due to exposure during childhood to ex-
cessive fluoride in local underground water. Our study,
conducted in 2001-2002 in Guangdong province, showed
that there were 396 villages with drinking water- related
endemic fluorosis affecting a total population of 502,400.
In Shantou City of Guangdong, there were 73 villages
(population of 216,000) in the endemic fluorosis areas
[15,16]. The water fluoride concentrations were much
higher than the national standard of 1.0 mg/l, ranging
from 1.0 mg/l to 11.6 mg /l, and the prevalence of dental
fluorosis was 62% among children aged 8-15 years [17-19].
As high fluoride drinking water seriously endangers
local residents’ health, Shantou was recognized as an en-
demic fluorosis city in 1980. To address health risks
associated with fluoride, public water with lower fluoride
(<1.0 mg/l) has gradually been introduced in the endemic
villages [20]. By 2008, public water (tap water or mountain
spring water) replaced well water in more than 93% of the
villages. Few or no studies have evaluated the health
impacts of this water change policy. It is yet to be
determined whether children’s health in these endemic
fluorosis areas has reached the level of children living in
non-fluorosis areas. In particular, no studies have
examined bone metabolism changes after the intervention
of supplying low fluoride water, especially with regard to
the changes in various biomarkers (exposure and bone
damage). In order to fill these knowledge gaps, this study
compared water fluoride, urinary fluoride (a measure of
internal exposure), and four bone metabolism indicators
including serum osteocalcin (BGP), calcitonin (CT), alka-
line phosphatase (ALP) and bone mineral density between
the four intervention villages and one control village.
Assessing endemic fluorosis is a daunting task for local
health departments. The key is to determine theallowable limit of the water fluoride levels. Before the
endemic fluorosis occurs, early indicators of bone dam-
age such as BGP, CT, ALP and bone mineral density
change. Therefore, it is important to determine the
thresholds for these bone indicators to assess early fluor-
ide impact to human health. In this study, the dose - re-
sponse relationship model was used to estimate safe
doses of water fluoride and urinary fluoride using the
above bone-related indicators, as well as to identify the
threshold relevant to bone metabolism indicators.
Finally, by evaluating the relationships between the urin-
ary fluoride (UF) and the four bone indicators, we iden-
tified the most sensitive and reliable bone metabolism
indicators to use in intervention efforts in endemic
fluorosis areas.Methods
Study population and design
This study was conducted in four of 13 endemic fluor-
osis villages (intervention villages) in Chaonan District
of Shantou, China, randomly selected for the observa-
tion group based on the years of having a public water
supply. The selected villages were Xiangang village (A)
of Sima town, Fanxi village (B) of Chendian town, Yiying
village (C) of Xiashan town and Xibei village (D) of
Chendian town. Shangnan village (E) of Jingdu town
served as the control village and was selected based on
its non-endemic fluorosis status as well as its similarity
in demographics (annual average income per person:
RMB 5,000 yuan and all rural, farming communities),
dietary habits and life styles (eating porridge, rice, fish,
and drinking a lot of high concentration of “Wulong” or
“Tieguanyin” (Wulong green tea), similar geographic
areas (all living within 10 KM from Lian river), similar
health status (no acute infectious diseases and chronic
diseases including bone metabolism-related diseases),
and similar medical insurance (New Cooperative Med-
ical System sponsored by local government), in villages
A, B, C and D. The investigation was conducted between
October 18, 2009 and November 15, 2009. A total of
600 school children (6-12 years old) were selected who
had resided since birth in their village of residence. Sam-
pling methods included:1) randomly selecting one school
from each village, 2) randomly selecting one class from
grades 1-6 from each selected school, and 3) randomly
selecting 20 children (50% boys and 50% girls) from each
selected class. All the children in the sample were
measured for UF, serum ALP, BGP, CT and bone mineral
density. Blood and urine samples were collected
following approval by the Medical Ethics Review Group
of Sun Yat-sen University School of Public Health and
informed consent from the principals of the schools and
the parents of the children.
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Drinking water samples were collected from peripheral taps
around the village and the center point of each village. Fifty
ml of each sample was collected in a clean and dry poly-
ethylene plastic bottle. The concentration of drinking water
fluoride was determined in the laboratory using the
ion electrode test based on the China’s Drinking Water
Standard Detection Method GB/T5750-2006 [21]. Urine
samples were collected from participating children at
11:00 am, and 50 ml of each sample was sent to the labora-
tory. Urinary fluoride content, an indicator of long-term
fluoride exposure, was determined using the fluoride ion
electrode method based on the China’s Urinary Fluoride
Detection-Fluoride Electrode Method WS/T89-1996 [22].
Quality control for water fluoride and urinary fluoride
Quality control of laboratory equipment was ensured
by regular instrument calibration [21,22]. Under the guid-
ance of the National Drinking Water Fluoride Content
Determination, the standard curve regression equation
for water fluoride determination is: y^ ¼ 311:34þ
52:971x r2 ¼ 0:9993ð Þ . The spiked recoveries of different
potential values ranged from 96.3%-102.0% (Normal Value
is between 95.0% and 105.0%). In addition, the standard
curve regression equation for the determination of fluor-
ide in urine is: y^ ¼ 25:118 348:89x r2 ¼ 0:9991ð Þ . The
relative error for 10 synthetic urine samples (1.25 mg/L)
is E=3.07%.Measurement of bone metabolism indicators
Serum BGP, CT and ALP testing and bone density
measurement
Venous blood samples (5 ml) were obtained using a vac-
uum blood tube from the upper arm of each participating
child. Blood and urine samples were collected simultan-
eously and at the same time of day for each village. It took
five days to complete this sample collection (one day
per village). The blood samples were placed in the labora-
tory refrigerator at a constant temperature of 4°C. Two
milliliters of serum was separated from each blood sample
next day and kept in the laboratory freezer at a constant
temperature of -20°C. Serum osteocalcin (BGP) and calci-
tonin (CT) contents were determined using radioimmuno-
assay (The intelligent Montioring γ radioimmunoassay
instrument (SN-695B) was from Rihuan instrument of
Shanghai nuclear research, China, a kit was developed by
Hengda Biological Technology Development Co., Ltd,
Nanjing, China.). The alkaline phosphatase (ALP) activity
was detected using benzene disodium phosphate method
(a kit from Nanjing Jiancheng Biotech Company in China).
Bone mineral density was measured by dual energy X-ray
bone densitometer (DTX-200 US Osteometer MediTech,
Inc. Signal Hill, USA) with the accuracy of one tenthousandth (g/cm2), The detection sites of bone mineral
density were the ulna and radius of the forearm.
Quality control and standard curves drawing
According to the concentration from low to high, six con-
centration groups were pooled to generate an average
value and to calculate the coefficient of variation (CV)%.
For instance, the CV% of BGP for the dose groups (from
low to high) were 1.55%, 0.37%, 0.22%, 4.35%, 3.66% and
1.00% respectively. The CV% of CT for the dose groups
(from low to high) were 0.49%, 0.80%, 1.17%, 1.13%, 2.77%
and 1.94% respectively. The standard curve was drawn
based on the average attenuation counts. Every sample for
BGP, CT and ALP determination had its own parallel sam-
ple (one sample divided into two for the same measures at
different times to ensure the reliability of the measure-
ment results, as well as to prevent system errors). All the
coefficients of variation were less than 10%.
The abnormal criteria of four bone metabolism indicators
The 90th percentile among children of the same gender
and age in the control village was used to identify
participants as normal or abnormal. Each individual’s bone
mineral density’s Z score was calculated using the formula:
Z score = (Xμ −Xm)/s, where Xμ = individual bone
mineral density; Xm = mean value of the control village
(Village E) group’s bone mineral density (stratified by
age and gender); and s = standard deviation. The abnor-
mal Z-value is Z<-2, from which we could obtain the
abnormal incidence of different doses for all the effect
indicators.
Data analysis
All data were presented as mean values with standard
deviations (SD). Statistical tests for significance were
performed using the one-way analysis of variance
(ANOVA), Kruskal-Wallis test, t test, Chi-square test and
Chi-square test for trend with SPSS ver. 17.0 software
(SPSS, Chicago, IL). Differences were considered to be
statistically significant at P < 0.05. While F-values were
found being significantly different among all intervention
villages combined compared to the control village, pair-
comparison tests were conducted to further determine
which intervention village was different from the control
village. Benchmark dose (BMD) modeling was conducted
using USEPA’s BMD Software v. 2.2 to obtain dose-
response relationships between the urinary fluoride and
the four bone indicators. Benchmark Response(BMR)was
used as a predetermined incidence of adverse response
that determines the Benchmark dose [23]. A BMR of 10%
was used to obtain four bone indicators along with appro-
priate 95% lower confidence limits (BMDL10). The best fit-
ting model was selected from the multi-models based on
the Akaike information criterion (AIC).
Table 2 Urinary fluoride levels after change of water
supply, Guangdong, China, 1992 to 2009
Village Years of using public water # of samples UF(mg/l) *
A 6 128 0.62 ± 0.38#
B 14 108 0.51 ± 0.42
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Comparisons of water -fluoride and urine-fluoride levels
between villages
In total, 550 children provided urine samples and of these,
24 children did not provide blood samples. Thus, there
were 526 children who provided both blood and urine
samples in the 5 villages studied. The four intervention
villages (A-D) received low-fluoride public drinking water
(< 1.0 mg/L) over a period of 6-17 years. The levels of
fluoride in the water prior to this period were compared
to the water-fluoride levels measured following the water
supply replacement (Table 1) as well as the level in the
control village (Village E). The data showed that the con-
centration of fluoride in the control village changed min-
imally during this period while the fluoride levels in
drinking water at the intervention villages (B, C and D)
declined by 95.8%-98.0% ,to levels similar to the control
village (0.11 mg/l) (t=1.567, P=0.215).
Urinary fluoride levels (UF) in intervention villages were
compared to those in the control village using the
Kruskal-Wallis test (Table 2). In general, the pooled aver-
age UF levels (0.430±0.380 mg/l) in the four intervention
villages were significantly lower or similar to the values in
the control group (0.480 ± 0.290 mg/l)(P<0.001).
Compared with the control village, children living at Vil-
lage C (0.360 mg/l) and D (0.270 mg/l) showed signifi-
cantly lower UF levels after receiving 15-17 years’ low
fluoride water supply using rank transformation and
Dunnett t-test. Children in Village B had similar UF levels
as those in the Control village after 14 years of water
change (no statistically significant differences). However,
the average UF levels for village A (0.620 ± 0.380 mg/l)
(after 6 years of intervention) were still significantly higher
than the control village E. Another interesting finding is
that urinary fluoride levels are higher than drinking water
fluoride levels (Table 1 & Table 2).
Comparison of BGP, CT, ALP and bone mineral density
between villages
The average serum levels of biomarkers Osteocalcin
(BGP), Calcitonin (CT) and Alkaline Phosphatase (ALP)
among the children in each of intervention villages A, B,Table 1 Water fluoride levels before and after the change
of public water supply, Guangdong, China, 1992 to 2009
Village
Change of public water supply






A 6 5.51 0.11
B 14 2.17 0.09
C 15 3.99 0.11
D 17 3.31 0.10
E Control 0.12 0.11C and D were compared to control village E (Table 3).
The pooled mean serum level for the four intervention
villages was also used for comparison to the control vil-
lage. While the pooled mean from Group A through D,
biomarkers BGP and ALP were significantly lower when
compared to the control village E (P<= 0.01), but the
mean of CT and Bone Density among the 4 intervention
villages were similar to those in the control village.
Significant differences were seen between the interven-
tion and control villages for all biomarkers and
indicators in the F tests (all P < 0.05, Table 3). Except
for Village A and C, the children’s serum BGP levels in
Villages B and D were significantly lower than that in
the village E in pairwise comparison (P < 0.05). For CT
levels, village A was higher than E, while village B and C
were lower than E. The ALP levels in the villages C and
D were significantly lower than E. Total bone mineral
density in pairwise comparisons showed no difference
between the intervention and control villages.
Analysis of urinary fluoride and bone metabolism
indicators
The relationships between increased UF concentrations
and abnormal bone indicators are described in Table 4. The
abnormal thresholds of the three bone indicators including
BGP (>19.24 μg/l), CT (>254.15 pg/ml), and ALP (>46 U/l)
were defined according to the 90% upper limit of the same
indicator with similar gender and age of children in the
control village. Bone mineral density was defined as abnor-
mal if the bone density Z value was<-2. All bone indicators
were analyzed by dividing the sampling children into 4
groups according to their urinary fluoride contents (mg/l)
as follows: 0 -<0.3, 0.3-<0.6, 0.6- <0.9 and 0.9- (Table 4).
From Table 4 we could find that the highest percentage of
the participating children with abnormal bone indicator is
CT (13.7%), followed by BGP (10.1%) and then ALP (8.8%),C 15 73 0.36 ± 0.12#
D 17 114 0.27 ± 0.28#
E Control 127 0.48 ± 0.29
Total - 529 0.44±0.35
Median* 0.43±0.38
*: In Shapiro-wilk test, urinary fluoride levels were not normally distributed
(P<0.05). Kruskal-Wallis test shows five Villages were statistically significant:
χ2=127.92, P=0.00.
#: Dunnett t-test method after rank transform for the pairwise comparisons,
the difference was statistically significant (P<0.05).
*: Pooled Median from group A through D; P values of Kolmogorov-Smirnov Z
test for median difference between pooled median and control median;
Z=1.63, P =0.01.
Table 3 Comparison of BGP、 CT、 ALP and Bone Mineral Density between the Intervention Villages and the Control
Village after Chang of Water Supply, Guangdong, China
Village
BGP(μg/L)* CT(pg/ml)* ALP(U/L)* Bone density (g/cm2)*
n χ  s n χ  s n χ  s n χ  s
A 119 16.19±3.18 120 256.44±103.39# 117 29.88±9.02 98 0.29±0.06
B 98 13.81±2.40# 98 156.81±57.82# 98 33.06±15.79 77 0.26±0.04
C 73 15.77±3.45 63 126.44±39.49# 73 27.02±7.56# 71 0.28±0.07
D 109 14.23±2.56# 111 179.48±57.66 108 25.39±7.06# 95 0.29±0.07
E 127 15.81±2.77 127 197.21±51.29 127 31.90±10.15 113 0.27±0.04
F 14.465 48.959 9.831 3.781
P 0.000 0.000 0.000 0.005
Normal range% (10.38,21.24) (96.68,297.74) (12.01,51.79) (0.19,0.35)
Mean* 15.14±2.90 190.80±72.84 29.21±10.53 0.28±0.06
P** = 0.01 > 0.1 < 0.01 ≈ 0.1
*: By Shapiro-wilk test, BGP ,CT ,ALP and Bone Density are normal distribution(P>0.05).
#: Pairwise comparisons using Dunnet t test method with the control village E, the difference was statistically significant (P<0.05).
%:Normal ranges were calculated according to the control village.
*: Pooled mean from group A through D.
**: P values of t test for mean difference between pooled mean and control mean.
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linear trend test using χ2 test showed that with the increase
of urinary fluoride, the abnormal rates of BGP and CT also
increased, but no such linear trends for ALP and bone min-
eral density with UF were observed.
Dose - response relationship between urinary fluoride
and bone metabolism indicators
We selected different analysis models to assess the dose-
response relationship between UF and four different bone
indicators based on data distribution and model fitness
(Figure 1). The Logistic regression model used to describe
the dose - response relationship between urinary fluoride
and BGP was: logit(P)=-2.553+0.955UF. The Quantal-
Linear model was selected to describe the dose - response
relationship between urinary fluoride content and CT,
which was P=0.085+0.915(1-exp(-0.166UF)). A logistic
model of dose-response relationship for urinary fluorideTable 4 Urinary Fluoride and Abnormal Incidences of Bone M
UF(mg/l)
BGP CT
n Abnormal(%) n Abnorma
0.0 ~ 120 9(7.5) 119 10 (8.4
0.3 ~ 252 22(8.7) 245 32(13.1
0.6 ~ 96 14(14.6) 96 17(17.7
0.9 + 58 8(13.8) 59 12(20.3
Total 526 53(10.1) 519 71(13.7
χ2 0.42 6.42
P 0.22 0.09
Trend test χ2 3.52 6.85
P 0.03 0.00and ALP was described as: logit(P)=-2.48+0.388UF, and
the model for urinary fluoride and bone mineral density
was Log-Logistic; the model used is: P=0.03+0.97(1+exp
(1.09-18ln(UF)))-1 (Figure 1:A-D). All the regression
models passed the goodness fit test and the results showed
that they fit well (P>0.05).
Among these four indicators, the Benchmark dose of
CT is the most sensitive one. When the abnormal rate of
it increases to 10%, the corresponding benchmark dose is
0.636 mg/l and 95% lower limit is 0.383 mg/l, which
means when the urinary fluoride changes to 0.383 mg/l,
the CT may undergo noteworthy abnormal changes. The
second most sensitive indicator is BGP (BMD and BMDL
were 0.975 mg/L and 0.622 mg/l respectively), i.e., when
the urinary fluoride changes to 0.622 mg/l, the risk of BGP
anomalies will reach 10%. The least sensitive indicators
are ALP (BMDL: 0.837 mg/l ) and bone mineral density
(BMDL: 0.881 mg/l) (Table 5). The dose - response curveetabolism Indicators among the UF concentration groups
ALP BMD
l(%) n Abnormal(%) n Abnormal(%)
) 119 11(9.2) 98 2(2.0)
) 245 17(6.8) 221 8(3.6)
) 96 13(13.5) 81 1(1.2)
) 59 5(8.8) 54 4(7.4)






















































Figure 1 A-D The Dose-response Relationship between Urine Fluoride and Bone Metabolism Indicators, Guangdong, China from 1992
to 2009.
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different from other indicators, which shows that at lower
doses of urinary fluoride, the anomalies of bone mineral
density changed little, but when the urinary fluoride
increased to a certain extent, the anomalies of bone min-
eral density changed significantly.
This study showed that with six or more years of
changed water fluoride levels, all the abnormal bone
indicators except for CT had declined to low levels
(Figure 2). However, abnormal CT did not decline till
around 10-14 years after the intervention. Bone mineral
density showed the lowest in all bone indicators and was
relatively stable over time.
Discussion
This study found that the water fluoride levels in villages
(A-D) after the water source change were much lower
than the average pre-intervention level (3.475 mg/l) and
the post-intervention levels in all intervention villages
declined to 0.11 mg/l or lower. These reduced fluorideTable 5 The BMD and BMDL of urine fluoride between
the abnormal incidences of bone metabolism indicators




A BGP Logistic 0.82 0.66 0.98 0.62
B CT Quantal-linear 0.05 0.98 0.64 0.38
C ALP Logistic 3.34 0.19 2.30 0.84
D Bone density Log-logistic 1.51 0.47 0.94 0.88levels are lower than the Chinese National Fluoride
Standard (1.0 mg/l), and the World Health Organization
(WHO) recommended drinking water fluoride levels of
0.5~1.5 mg/l. The fluoride concentration of drinking
water is the only objective indicator reflecting drinking
water source of endemic fluorosis and environmental
fluoride, and for evaluating the policy effect of water
change/treatment in the endemic fluorosis areas. As
most fluoride intake in the endemic fluorosis areas of
China were from drinking water, it is appropriate to
monitor the fluoride level in drinking water in endemic
areas and over time.
We also found that urinary fluoride levels among the
residents living in the villages after 14-15 years of water
source change were similar or lower than the level in the
control village. In other words, over the years that the
high fluoride water was replaced by lower fluoride water
(public water), urinary fluoride excretion had gradually
decreased. Urinary fluoride (UF), is an objective measure
of fluoride intake, because it is related to the water fluor-
ide and reflects the human level of fluoride metabolism
[24]. Our study also found that the urinary fluoride
concentrations declined the longer the villages had ac-
cess to the public water supply, which was supported by
similar results found in other studies [25,26]. Gongju
Yin et. al. conducted a survey among children aged 8-12
in the fluorosis areas and found that drinking water de-
fluoridation resulted in water fluoride concentration re-
duction and consequent reduction in urinary fluoride
[27]. The results from these prior studies are consistent
Figure 2 Time Trends of Abnormal Rates in Bone Metabolism Indicators after the Change of Public Water Supply, Guangdong, China
from 1992 to 2009.
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ide among children in intervention villages having a
public water supply for more than 10 years (villages B, C
and D) was similar to the level of UF in the control vil-
lage. However, the children’s UF in village A is still higher
than the control village probably due to a shorter time (6 -
years) of having a public water supply. An interesting
finding from our study was that urinary fluoride levels are
higher than drinking water fluoride which may be due to
the accumulation of fluoride in the body; i.e., fluoride
released from bone or other body tissues and excreted
through the kidneys. It could also be due to the body ac-
cumulation of fluoride from other sources such as tea,
local-grown vegetables, fruits or animals. This process
could take place over a long period of time.
Long-term intake of excessive fluoride has adverse
effects on health including dental fluorosis, change of
bone metabolism indicators, and finally bone damage
[28-32]. After a long period of low-fluoride public water
exposure, all the indicators had reached to the normal
level after the water changed for six years or more ex-
cept for CT. These findings imply the success of the pol-
icy of fluoride water change and are consistent with the
relationship between urinary fluoride and fluoride-
induced bone metabolism indicators including BGP, CT,
ALP, and bone mineral density reported by one of the
few studies in this area [33,34].
To select the best bone metabolism indicators related
to high fluoride exposure, this study also examined the
dose-response relationship between children’s urinary
fluoride level and abnormal bone indicators. We found
that children’s abnormal levels of BGP and CT increased
as the levels of their urinary fluoride contents increased,
but this dose-response relationship was not as apparent
with respect to serum ALP levels and bone mass density.
All of these four indicators can reflect the impact of
fluoride on bone metabolism, including bone formationand bone resorption, which is accelerated and is the rea-
son of osteosclerosis and bone softening due to the skel-
etal fluorosis.
Serum BGP, CT and ALP are commonly used as markers
reflecting bone generation. As Liang et.al. described [35],
BGP, a collagen protein produced and secreted by
osteoblasts, could regulate the bone metabolism through
binding with hydroxyapatite (HA) to form fluoride phos-
phate stone. This results in the increase of BGP secretion,
destruction of normal bone mineralization rate, and induc-
tion of osteomalacia and osteoporosis [36]. Therefore,
serum BGP is a sensitive, specific, accurate and simple bio-
chemical indicator to measure instantaneous change of
bone metabolism [37-40]. ALP has been considered as a
marker of osteoblast activity. Fluoride can affect ALP activ-
ity in two ways. i.e., changing the structure of the enzyme
to directly affect the activity of the enzyme, and accumulat-
ing fluorine in the bone to promote bone cells in mitosis,
and thus influence vitality of the bone cells. Therefore, the
increase of serum ALP, to some extent, reflects an active
cell proliferation of the osteoblasts, and suggests that the
body that may have fluorosis-related damage. Wan stated
that after exclusion of other metabolic bone diseases,
elevated serum ALP can be used as a diagnostic indicator
of skeletal fluorosis [41]. Liu has shown that when the
fluoride concentration in drinking water reaches 0.58mg/l-
1.59 mg/l, ALP activity is increased [42]. When the water
fluoride concentration is between 1.60mg/l and-3.37 mg/l,
ALP activity decreases slowly. It could decrease to as low
as 57% of the normal amount, but it can return to normal
levels some time later [43]. ALP has been thus recognized
as an early and important indicator in the evaluation of
bone formation and bone turnover. In addition, the main
role of CT is to stimulate osteoblast formation and indir-
ectly affect bone metabolism [44,45]. The sensitivity and
specificity of CT are lower than those of BGP and ALP. Fi-
nally, bone mineral density, reflecting per unit volume of
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tor for evaluating bone mass. Skeletal fluorosis caused by
osteoporosis reduces per unit volume of bone mass, i.e.,
decreases the bone mineral density. The measurement of
bone mineral density can be used as a more objective and
accurate evaluation indicator of bone changes [46]. In
summary, BGP, ALP, and CT reflect pre-bone formation
status, but bone mass density indicates final bone mineral
change. Thus, use of all these four indicators not only
demonstrate early changes of bone metabolism, but also
describe the final mineral characteristics in order for us to
evaluate the new regulation of supplying public water in
the endemic fluorosis areas.
The benchmark dose–response models were first
mentioned by Crump [23]. A BMD is defined as the dose
that corresponds to a specified change in adverse response
compared to the response in untreated situation. The dose
is associated with a given incidence (e.g., 1%, 5% or 10%
incidence) of effect, the Benchmark Response, based on
the best fitting dose-response curve in the region of the
dose-response relationship where biologically observable
data are available. The resulting BMD in this study is
termed BMD10 for a 10% incidence.
Because these four bone metabolism indicators are the
physiological continuity indicators of the bone metabol-
ism or damage, we need to identify a cut-off point or
threshold to define abnormal value based on the dose-
response relationship. This study found that CT has the
lowest threshold or BMD among all bone metabolism
indicators, but ALP has the highest BMD. Unfortunately,
no available literature can be found to compare with our
findings. This study also found that most bone damage
markers went back to normal level after six years of
water change intervention except for CT which signifi-
cantly declined after 10-14 years. Bone mineral density
is the most stable indicator. No other studies are avail-
able to compare with our findings.
This study is one of the only or few research efforts to
evaluate how this environmental intervention affected
public health. We not only examined fluoride change
(external exposure marker) in public water after provid-
ing low fluoride water, but also assessed UF (internal ex-
posure marker) and bone damage related to fluoride
exposure (health markers). Different from some prior
studies which relied completely on self-reported infor-
mation, use of these comprehensive biomarkers from ex-
posure to health endpoints minimized reporting bias
and provided reliable data for intervention evaluation.
This study may also be the first to describe and compare
the changes of several pre-clinical and clinical bone me-
tabolism markers after intervention, which could help in
understanding the potential biological mechanism and
identify sensitive or appropriate health indicators for fu-
ture public health surveillance.One of the major limitations in this study is lack of
baseline data for UF and bone metabolism indicators
prior to water source change. However, a control village
was carefully selected for comparison based on similar
status as the intervention villages (A-D) on demographic
characteristics (annual income, insurance type, and all
rural, farming communities), dietary habits (eating por-
ridge, rice, fish, and drinking a lot of high concentration
of tea), similar geographic areas (all near river), and
similar health status for participant students by exclud-
ing those with infectious diseases and bone metabolism
disorders. In other words, all living conditions between
the intervention villages and the control village were
similar except for water sources. In this study, since the
public water supply to all fluorosis endemic areas had
similar concentrations of fluoride, and the fluoride levels
in all intervention villages were reduced to levels similar
to the non-fluorosis endemic areas, it is not possible to
assess the dose - response relationship between water
fluoride and the indicators. Nevertheless, we did use
“the years of having the new water source” as an indica-
tor to assess the health impact of duration of water
intervention. In addition, as most previous studies in this
area were conducted in China or other countries, limited
English literature was available to compare with our
findings. Finally, although this study demonstrated the
success of the environmental intervention program, i.e.,
providing low-fluoride water supply in all endemic villages
in Guangdong province, similar or even lower values of
fluoride in some intervention villages compared to the
control village or under the national health standards
(1.0 mg/l) caught the attention of local environmental and
public health agencies with respect to dental caries. There-
fore, the possibility that the drinking water with very low
concentration of fluoride could induce dental caries in
these area and whether fluoride levels in the water supply
of these villages should be modified, is worthy of the fur-
ther study.Conclusion
In summary, when public water with low fluoride concen-
tration was supplied to endemic fluorosis villages for more
than 6 years, the children’s urinary fluoride decreased to
the normal range. Urinary fluoride content is reduced
more the longer the duration of the change in the public
water supply. Consistently, almost all the fluoride-induced
bone metabolism indicators of the study population in the
intervention villages have reached the normal level or
levels lower than those of the control village. Among all
the bone metabolism indicators, BGP and CT are the most
sensitive indicators related to UF based on BMD, but ab-
normal bone mineral density was the lowest overtime and
showed the most stable change after the intervention.
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